An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClip™ Device (bRIGHT)

Active, not recruitingOBSERVATIONAL
Enrollment

511

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

December 31, 2027

Study Completion Date

January 31, 2028

Conditions
Tricuspid Valve Regurgitation
Interventions
DEVICE

Transcatheter heart valve procedure

Transcatheter treatment of TR with Abbott TriClip™.

Trial Locations (26)

3010

Inselspital Bern, Bern

8032

HerzKlinik Hirslanden - Klinik Hirslanden, Zurich

53127

University Hospital Bonn, Bonn

55131

Universitatsmedizin der Johannes Gutenberg-Universitat Mainz, Mainz

Unknown

Universitätsklinik Graz, Graz

Odense University Hospital, Odense

Zentralklinik Bad Berka GmbH, Bad Berka

Herz-und Diabetes Zentrum NRW, Bad Oeynhausen

Schüchtermann-Schiller´sche Kliniken GmbH & Co. KG, Bad Rothenfelde

DRK Kliniken Köpenick, Berlin

St.-Johannes-Hospital, Dortmund

Elisabeth-Krankenhaus Essen GmbH, Essen

Katholisches Marienkrankenhaus GmbH, Hamburg

UKE Hamburg (Universitatsklinik Eppendorf), Hamburg

Otto-von-Guericke-Universität Magdeburg, Magdeburg

Robert-Bosch-Krankenhaus, Stuttgart

Universitätsklinikum Ulm, Ulm

Maria Cecilia Hospital, Cotignola

Azienda Ospedaliera Monaldi, Napoli

Universita degli Studi di Padova, Padua

St. Antonius Ziekenhuis, Nieuwegein

Centro Hospitalar Vila Nova de Gaia, Porto

Hospital Álvaro Cunqueiro, Vigo

04289

Leipzig Heart Center, Leipzig

08025

Hospital de Sant Pau, Barcelona

08036

Clinical and Provincial Hospital of Barcelona, Barcelona

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY